Efficay and safety of teriparatide treatment

Abstract

Teriparatide is the only available anabolic drug for treatment of post-menopausal and glucocorticoid-induced osteoporosis. Recent studies demonstrated the efficacy of teriparatide, but few data are available concerning treatment adherence and tolerance. We studied 165 patients treated with teriparatide from 2005 to 2012, with the aim to evaluate long term therapy efficacy, safety and tolerance. Our data demonstrate the efficacy of teriparatide in reducing back pain and preventing new fractures in a large group of patients, and indicate good tolerance and adherence to therapy